Medinotec Inc. splits its revenue into 4 lines in its filings. The largest line in Q2 of fiscal 2027, the quarter ended Aug 31, 2026 was Outside USA Distribution Agreement Sales at $2.8 million, 86% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Aug 31, 2026
|
Q2 FY2027
Aug 31, 2026
|
Q1 FY2027
May 31, 2026
|
Q4 FY2026
Feb 28, 2026
|
Q3 FY2026
Nov 30, 2025
|
Q2 FY2026
Aug 31, 2025
|
Q1 FY2026
May 31, 2025
|
Q4 FY2025
Feb 28, 2025
|
Q3 FY2025
Nov 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10
|
3
|
3
|
2
|
3
|
3
|
2
|
4
|
3
|
| Outside The United States |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
3
share 95.3%
|
—
|
| Outside USA Distribution Agreement Sales |
9
-12.6%
share 83.5%
|
3
-1.4%
share 86.1%
|
2
+31.0%
share 81.3%
|
1
-55.1%
share 75.8%
|
2
-1.6%
share 85.3%
|
3
share 86.3%
|
2
share 77.1%
|
3
share 87.1%
|
2
share 85.7%
|
| Outside USA Internally Designed Manufactured Sales |
1
-13.4%
share 8.5%
|
0
-21.2%
share 7.7%
|
0
-36.4%
share 8.1%
|
0
share 13.0%
|
0
+63.2%
share 9.7%
|
0
share 9.7%
|
0
share 15.9%
|
—
|
0
share 5.9%
|
| Inside USA Internally Designed Manufactured Sales |
1
+22.8%
share 7.9%
|
0
+52.7%
share 6.3%
|
0
+86.7%
share 10.6%
|
0
+24.6%
share 11.2%
|
0
-41.4%
share 5.0%
|
0
share 4.0%
|
0
share 7.0%
|
0
share 4.7%
|
0
share 8.4%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDNC (OTC)
- Fiscal year ends
- February 28
- Incorporated in
- NV
- Headquarters
- Johannesburg
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1931055
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.